DiscoverESICM TalkARDS Phenotyping: from disease understanding to future bedside perspectives
ARDS Phenotyping: from disease understanding to future bedside perspectives

ARDS Phenotyping: from disease understanding to future bedside perspectives

Update: 2024-06-191
Share

Description

To date, no specific pharmacotherapy has proven effective against acute respiratory distress syndrome ARDS. Results on the research domain have been ineffective in human trials, a gap attributed in part to clinical and biological heterogeneity in human ARDS. Therefore, a precision medicine approach is intended to address explicitly how such underlying heterogeneity influences response to therapy among different patients with the same diagnosis. “You can find treatment for the disease but not for syndromes and ICU is a syndrome-forward approach to patient care” says Dr Pratik Sinha who is working on ARDS phenotyping.

Listen to his interview and learn more about ARDS from disease understanding to future bedside perspectives.

Comments 
In Channel
N&AHP – ICU diaries

N&AHP – ICU diaries

2024-05-2220:57

loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

ARDS Phenotyping: from disease understanding to future bedside perspectives

ARDS Phenotyping: from disease understanding to future bedside perspectives

ESICM